[Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
D000086:Acetazolamide; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001639:Bicarbonates; D002927:Cimetidine / Q000627:therapeutic use*; D004338:Drug Combinations; D004381:Duodenal Ulcer / Q000188:drug therapy; D006146:Guanidines / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy*; D013276:Stomach Ulcer / Q000188:drug therapy
D000897:Anti-Ulcer Agents; D001639:Bicarbonates; D004338:Drug Combinations; D006146:Guanidines; D006635:Histamine H2 Antagonists; C030084:Ulcosilvanil; D002927:Cimetidine; D000086:Acetazolamide
Evolkuţia clinică, secretorie, radiologică şi endoscopica bolnavilor cu ulcere gastroduodenale trataţi cu ulcosilvanil, comparativ cu tratamentul cu antagonişti ai receptorilor H2 histaminici.